Find participating medical centers and current study status in each of them

    Find participating medical centers

    Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

    • Cancer
    • Renal Cell Cancer (RCC)
    • Carcinoma
    • Cholangiocarcinoma
    • Pancreatic Cancer
    • Papillary carcinoma
    • Papillary Thyroid Cancer
    • Solid Tumors
    • Skin Cancer
    • Malignant Melanoma
    • Renal Cell Carcinoma
    • Head and Neck Cancer
    • Salivary gland cancer
    • Sarcoma
    • Non Hodgkin Lymphoma (NHL)
    • Lymphoma
    • Colorectal Cancer (CRC)
    • Lung Cancer
    • Non Small Cell Lung Carcinoma
    • Tumor
    • Neoplasms
    • NeuroEndocrine Tumor (NET)
    • Ovarian Cancer
    • Breast Cancer
    • Thyroid Cancer
    • Melanoma
    • Head and Neck Neoplasms